Fate Therapeutics (NASDAQ:FATE) released its Q4 earnings on Thursday, February 26, 2026 at 09:00 AM.

Here’s what’s important from the earnings announcement.

Earnings

Fate Therapeutics missed estimated earnings by 0.0%, reporting an EPS of $-0.27 versus an estimate of $-0.27.

Revenue was down $491 thousand from the same period last year.

Analysis of Past Earnings

The company beat on EPS by …

Full story available on Benzinga.com